特拉斯图祖马布德鲁克斯提可有效控制复发性卵巢大细胞神经内分泌癌与低水平的HER-2表达:一个病例报告
Yurou Xing1, Yidan Cao2, Xin Wu3
1Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in oncology
|February 12, 2024
概括
卵巢的大细胞神经内分泌癌 (LCNEC) 是一种罕见且具有攻击性的癌症. 特拉斯图祖马布德鲁克斯泰坎对复发性卵巢LCNEC与低HER2表达有前途,提供了一个新的治疗途径.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 翻译研究是翻译研究.
背景情况:
- 卵巢的大细胞神经内分泌癌 (LCNEC) 是一个罕见而有侵略性的临床挑战.
- 对于卵巢LCNEC的最佳治疗策略仍未确定,手术和化疗是常见的方法.
研究的目的:
- 报告一个用trastuzumab deruxtecan治疗的卵巢LCNEC复发病例.
- 为了评估在HER2表达较低的患者中,特拉斯图祖马布deruxtecan的疗效.
主要方法:
- 一个55岁妇女的病例报告,患有复发性卵巢LCNEC.
- 免疫组织化学评估人类表皮生长因子受体2 (HER2) 的表达.
- 使用特鲁苏马布德鲁克斯泰坎 (T-DXd) 的治疗.
主要成果:
- 患者经历了瘤进展,尽管进行了彻底的手术和多种疗法.
- 免疫组织化学检查显示,在复发瘤中,HER2的表达水平较低.
- 用trastuzumab deruxtecan治疗导致显著减少瘤负担.
- 实现了4个月的无进展生存期 (PFS).
结论:
- 特拉斯图祖马布德鲁克斯泰康可能是复发性卵巢LCNEC的可行治疗选择,即使HER2表达率低.
- 这一案例表明了对一种罕见且具有攻击性的妇科癌症的潜在治疗途径.
- 对卵巢LCNEC的HER2向疗法进行进一步的研究是有必要的.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


